Suppr超能文献

遗传性痉挛性截瘫患者功能性步态的进展

Progression of Functional Gait in Hereditary Spastic Paraplegias.

作者信息

Cubillos-Arcila Diana Maria, Machado Gustavo Dariva, Sehnem Lauren, Burguêz Daniela, Zanardi Ana Paula Janner, Martins Valéria Feijó, Peyré-Tartaruga Leonardo Alexandre, Saute Jonas Alex Morales

机构信息

Graduate Program in Medicine, Medical Sciences, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.

Exercise Research Laboratory, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.

出版信息

Cerebellum. 2022 Jun;21(3):350-357. doi: 10.1007/s12311-021-01302-2. Epub 2021 Jul 9.

Abstract

Hereditary spastic paraplegias (HSP) are characterized by progressive deterioration of axonal projections of upper motor neurons leading to abnormal locomotion. The clinical course of HSP as well as the definition of the best instruments to assess its progression is largely unknown. The aim of this study was to investigate the progression of functional gait in individuals with HSP and to define sensitivity to change, minimal clinically important difference (MCID), and validity of timed functional tests of gait (TFT). The study was constituted of two phases: a cross-sectional study and a prospective cohort of 18 months. Twenty-five patients (17 being SPG4), and twenty-five age- and sex-matched control individuals performed TFT. Spastic paraplegia rating scale (SPRS), ten-meter walking test (10MWT), timed up and go test (TUG), both at self-selected and maximal walking speeds, and six-minute walking test (6MWT) were performed on baseline in both groups and after 18 months of follow-up only in the HSP cohort. In the cross-sectional analysis, all TFTs performances were greatly impaired in HSP patients compared to controls. After 18 months of follow-up, TFTs did not differ significantly from baseline in the statistical analysis, with some tests showing more frequent improvement than worsening. We have provided effect size measures and MCID for the evaluated instruments. HSPs clearly compromised TFTs performances, which were valid instruments for assessing disease severity. However, TFTs and SPRS did not capture the very slow motor evolution of HSPs, reinforcing the necessity of additional biomarkers of disease progression.

摘要

遗传性痉挛性截瘫(HSP)的特征是上运动神经元轴突投射逐渐退化,导致异常运动。HSP的临床病程以及评估其进展的最佳工具的定义在很大程度上尚不清楚。本研究的目的是调查HSP患者的功能性步态进展情况,并确定对变化的敏感性、最小临床重要差异(MCID)以及步态定时功能测试(TFT)的有效性。该研究由两个阶段组成:横断面研究和为期18个月的前瞻性队列研究。25名患者(17名为SPG4型)和25名年龄及性别匹配的对照个体进行了TFT测试。两组在基线时均进行了痉挛性截瘫评定量表(SPRS)、十米步行测试(10MWT)、自选和最大步行速度下的计时起立行走测试(TUG)以及六分钟步行测试(6MWT),而仅在HSP队列中进行了18个月的随访后测试。在横断面分析中,与对照组相比,HSP患者的所有TFT测试表现均受到严重损害。经过18个月的随访,在统计分析中TFT测试与基线相比无显著差异,一些测试显示改善比恶化更为频繁。我们为评估的工具提供了效应量测量值和MCID。HSP明显损害了TFT测试表现,这些测试是评估疾病严重程度的有效工具。然而,TFT测试和SPRS未能捕捉到HSP非常缓慢的运动进展,这进一步凸显了疾病进展的其他生物标志物的必要性。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验